Caroline-1 Clinical Trial

The Caroline Foundation and the Cancer Clinical Research Trust are delighted to announce that the ‘Caroline 1 Trial‘ for patients with first-line HER2+ MBC will be initiated January 6th 2020. We are so proud to support the work of Professor John Crown and that of our dedicated researchers Dr Denis Collins and Dr Nicola Gaynor of the National Institute for Cellular Biotechnology in DCU, and those whose work has led to this trial Dr Norma O’Donovan & Cancer Clinical Research Trust.  May this trial lead to new insights & treatments.